Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
9.67
-0.55 (-5.43%)
Mar 31, 2025, 1:40 PM EDT - Market open

Greenwich LifeSciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Selling, General & Admin
1.641.631.561.040.810.82
Upgrade
Research & Development
9.137.76.483.561.062.61
Upgrade
Operating Expenses
10.769.338.044.61.863.43
Upgrade
Operating Income
-10.76-9.33-8.04-4.6-1.86-3.43
Upgrade
Interest & Investment Income
0.270.440.220.030-
Upgrade
Pretax Income
-10.5-8.89-7.83-4.57-1.86-3.43
Upgrade
Net Income
-10.5-8.89-7.83-4.57-1.86-3.43
Upgrade
Net Income to Common
-10.5-8.89-7.83-4.57-1.86-3.43
Upgrade
Shares Outstanding (Basic)
1313131392
Upgrade
Shares Outstanding (Diluted)
1313131392
Upgrade
Shares Change (YoY)
1.49%-0.51%-0.23%36.27%320.69%1012.34%
Upgrade
EPS (Basic)
-0.81-0.69-0.61-0.35-0.20-1.52
Upgrade
EPS (Diluted)
-0.81-0.69-0.61-0.35-0.20-1.52
Upgrade
EBITDA
-10.76-9.32-8.04-4.59-1.86-3.42
Upgrade
D&A For EBITDA
000000
Upgrade
EBIT
-10.76-9.33-8.04-4.6-1.86-3.43
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q